Mankind Pharma shares jump 10% on robust Q1; up 77% against IPO price
The pharma major reported 66% YoY growth in net profit at ₹494 crore, while sales rose 18% YoY to ₹2,579 crore in Q1FY24.
manforce
August 2023
April 2023
Despite muted response from retail investors, Mankind Pharma IPO subscribed 15 times
The portion reserved for QIBs was subscribed over 49 times, while quota for NIIs and retail investors were booked 3.8% times and 0.9 times, respectively.
